ARCHIVES

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | August 30, 1974

Download PDF Visit The Full Archive

Related Articles

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

Seattle Cancer Care Alliance Outpatient Clinic to Open – Jan. 19, 2001

June 7, 2021

FDA Forms Office of Combination Products;

January 10, 2003

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

Approval Granted For New Formulation of Lupron Depot

July 29, 2011